OBIO CAAP Companies Awarded Funding by Ontario Health Technologies Fund

In 2017-18, $5.47 million will be distributed to 12 projects through the Health Technologies Fund. 3 CAAP companies are among the Health Innovation project teams which received funding. Congratulations to Komodo OpenLabs, Eve Medical and BrainFx!

Read about the projects and funding details

 

Previous
Previous

OBIO CAAP Company: Winterlight Labs Enters New Collaboration with Johnson & Johnson Innovation

Next
Next

PreCAAP Company: Tracery Opthalmics Wins $50K First Prize at JLABS AI for Drug Discovery QuickFire Challenge